Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
30.81
+0.07 (0.23%)
Nov 22, 2024, 4:00 PM EST - Market closed
Tandem Diabetes Care Market Cap
Tandem Diabetes Care has a market cap or net worth of $2.02 billion as of November 22, 2024. Its market cap has increased by 90.84% in one year.
Market Cap
2.02B
Enterprise Value
2.03B
1-Year Change
90.84%
Ranking
Category
Stock Price
$30.81
Market Cap Chart
Since December 31, 2013, Tandem Diabetes Care's market cap has increased from $591.10M to $2.02B, an increase of 242.33%. That is a compound annual growth rate of 11.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.98B | 2.65% |
| Dec 29, 2023 | 1.93B | -33.26% |
| Dec 30, 2022 | 2.89B | -69.78% |
| Dec 31, 2021 | 9.56B | 60.70% |
| Dec 31, 2020 | 5.95B | 68.94% |
| Dec 31, 2019 | 3.52B | 61.71% |
| Dec 31, 2018 | 2.18B | 9,014.23% |
| Dec 29, 2017 | 23.90M | -63.73% |
| Dec 30, 2016 | 65.90M | -81.45% |
| Dec 31, 2015 | 355.20M | 18.99% |
| Dec 31, 2014 | 298.50M | -49.50% |
| Dec 31, 2013 | 591.10M | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 2.11B |
| Mirum Pharmaceuticals | 2.10B |
| Azenta | 2.03B |
| Astrana Health | 2.02B |
| Supernus Pharmaceuticals | 1.99B |
| NeoGenomics | 1.97B |
| Beam Therapeutics | 1.95B |
| Omnicell | 1.94B |